Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
08/2008
08/12/2008US7411095 obtained using specific secondary amines are unexpectedly stable against water; reacting an aldehyde or ketone with an amine and treating the resulting reaction mixture with an acidic aqueous solution
08/12/2008US7410964 Cyclohexyl sulphones as gamma-secretase inhibitors
08/07/2008WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity
08/07/2008US20080188490 e.g. 1-(3-Chloro-phenylethynyl)-3-(3,4-difluoro-phenylamino)-cyclohexanol; metabotropic glutamate receptors modulator/antagonist;
08/07/2008US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
08/07/2008US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine
08/07/2008US20080187978 Anti-inflammatory medicaments
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1951697A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008CN100408625C Thermoplasltic elastomer composition
08/06/2008CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/05/2008US7408068 Compounds for the treatment of neurodegenerative disorders
08/05/2008CA2279319C Benzofurazan compounds which enhance ampa receptor activity
07/2008
07/31/2008US20080182992 Mitotic Kinesin Inhibitors and Methods of Use Thereof
07/29/2008US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy
07/29/2008CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
07/24/2008WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use
07/24/2008WO2008032858A3 Thiadiazole compound and use thereof
07/24/2008US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/24/2008US20080176830 Compounds, Compositions, and Methods
07/17/2008WO2008084872A1 Hydrazone derivative
07/17/2008US20080171737 Cyclic sulfonamide derivatives and methods of their use
07/16/2008EP1574505B1 1,2,4-thiadiazole compounds and use thereof
07/16/2008CN100402512C Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/15/2008CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition
07/10/2008WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase
07/10/2008US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester
07/10/2008US20080167303 Aryl sulfamide derivatives and methods of their use
07/09/2008CN101218237A Oxime derivative and preparations thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/08/2008US7396960 Diphenyl(vinyloxyhydrocarbyloxybenzene)sulfonium salts, e.g., p-vinyloxyethoxyphenyldiphenylsulfonium perfluorobutanesulfonate or cyclo(1,3-perfluoropropanedisulfon)imide; acid generating photoinitiators with good photoresist compatability
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077507A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase
07/03/2008US20080161366 Aminoalkyl substituted aryl sulfamide derivatives and methods of their use
07/03/2008US20080161295 e.g. 3-(2,2-dioxido-1-phenyl-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl)-N-methylpropan-1-amine; monoamine reuptake inhibitors; antidepressant, anxiolytic, anticarcinogenic, antiinflammatory, antidiabetic agent; hyperactivity, sleep disturbance, social phobia, chronic fatigue syndrome, viral infection
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
07/02/2008EP1937659A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
07/02/2008EP1937658A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
07/02/2008EP1937657A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
07/02/2008CN100399195C Azine-based charge transport materials
07/02/2008CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
06/2008
06/26/2008WO2008077138A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
06/26/2008WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
06/26/2008WO2008075026A1 4-hydr0xy-2-0x0-2, 3 -dihydro- 1, 3-benzothiazol- 7yl compounds for modulation of b2-adrenoreceptor activity
06/26/2008WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof
06/26/2008US20080153886 4-Benzyl-[1,2,4]thiadiazolidine-3,5-dione or thione derivatives are used to treat nerve damage associated with prion diseases, Creutzfeld-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, muscular dystrophy, diabetic neuropathy, optic nerve injury, glaucoma, depression, bipolar disease, and ADT
06/26/2008US20080153835 Therapeutic agents useful for treating pain
06/26/2008CA2673368A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
06/26/2008CA2672811A1 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7yl compounds for modulation of b2-adrenoreceptor activity
06/26/2008CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
06/26/2008CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
06/25/2008EP1934193A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208318A 1,2,4-thiadiazole compound, its use for controlling harmful organism and intermediate thereof
06/25/2008CN101205217A Compound, composite nano particle, grease and production methods thereof
06/25/2008CN100396673C New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
06/24/2008US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
06/19/2008WO2008073958A2 Substituted benzothiadiazinedioxide derivatives and methods of their use
06/19/2008WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use
06/19/2008WO2008073459A1 Aryl sulfamide derivatives and methods of their use
06/19/2008WO2008071421A1 Nitrate esters of carbonic anhydrase inhibitors
06/19/2008US20080146625 Oxime glucokinase activators
06/19/2008US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase
06/19/2008CA2671844A1 Aryl sulfamide derivatives and methods of their use
06/17/2008US7388097 controlling microorganisms; microbiocides; fungicides
06/17/2008CA2286772C Fungicide active substance combinations
06/12/2008US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives
06/12/2008US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia
06/12/2008US20080138291 e.g. (4-Sulfamoylphenyl)thioureido fluorescein; bind to the enzyme under hypoxic conditions and are able to reverse the tumor acidification mediated by the enzyme; fluorescent dye for tumor detection by positron-emission tomography; antitumor, antiproliferative agent
06/12/2008US20080134448 vivid color to hair without causing decomposition of the direct azo dye; excellent fastness to light, wash, sweat, friction and heat; stable to alkalizing agents and oxidizing agents; 4-azo-2,1,3-BENZOTHIADIAZOLE dyes
06/11/2008CN100394308C Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups
06/11/2008CN100393713C Therapeutic agents useful for treating pain
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7384967 Aryl carbonyl derivatives as therapeutic agents
06/10/2008CA2280668C An improved process for the conversion of 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole (tda) to 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (tda sulfone)
06/05/2008US20080132551 Positive allosteric modulators of the nicotinic acetylcholine receptor
06/05/2008US20080132511 Sulfonamide compounds
06/05/2008US20080132506 Anti-inflammatory medicaments
06/04/2008EP1926718A1 Pesticide thiazolyloxy substituted phenylamidine derivatives
06/04/2008EP1343775B1 Piperazine derivatives
06/04/2008EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/04/2008CN101193878A Agent for treatment of solid tumor
06/04/2008CN101193877A Agent for treatment of hematopoietic tumor
06/04/2008CN100391950C 1,2,4-thiadiazole compounds and use thereof
05/2008
05/29/2008WO2008061781A1 Thiadiazole derivatives for the treatment of neuro-degenerative diseases
05/29/2008WO2008042928A3 Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof
05/29/2008US20080125469 Thiadiazole compounds and methods of use thereof
05/28/2008EP1603891B1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/27/2008US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/27/2008US7378448 Diphenylether amide derivatives as opioid receptor antagonists
05/27/2008US7378414 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone
05/27/2008CA2272063C Antithrombotic organic nitrates
05/22/2008WO2008059128A1 Phenylic derivatives and use thereof as drugs
05/22/2008WO2008059025A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 100